Health - Google News: Isis Pharma tumbles on Kynamro cancer concerns - Businessweek

Health - Google News Google News

Isis Pharma tumbles on Kynamro cancer concerns - Businessweek Oct 16th 2012, 17:42 Isis Pharma tumbles on Kynamro cancer concerns Businessweek NEW YORK (AP) — Shares of Isis Pharmaceuticals Inc. skidded Tuesday as regulators raised questions about links between the company's experimental cholesterol drug Kynamro and cancer. THE SPARK: Isis and its partner Genzyme will discuss Kynamro ... PropThink: Safety Concerns with Kynamro Battering ISIS Ahead of Advisory ...Reuters Aegerion, Isis, Sanofi Make Case for Drugs to Treat Severe CholesterolMinyanville.com US HOT STOCKS: Citigroup, Bankrate, Isis PharmaceuticalsWall Street Journal Bloomberg -Benzinga -Jags Report all 12 news articles »

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

Posted in: